Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells

A Peairs1, A Radjavi, S Davis

  • 1Virginia College of Osteopathic Medicine, Blacksburg, VA 24060, USA.

Insights

AMP-activated protein kinase (AMPK) activation by AICAR inhibits inflammatory mediator production in kidney cells. This suggests AICAR may be a therapeutic target for inflammatory diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma) stimulate inflammatory mediator production.
  • MRL/lpr mice exhibit a heightened inflammatory response.
  • AMP-activated protein kinase (AMPK) activation by 5-amino-4-imidazole carboxamide riboside (AICAR) is known to inhibit certain inflammatory pathways.

Purpose of the Study:

  • To investigate the effect of AMPK activation on inflammatory mediator production in stimulated kidney mesangial cells from MRL/lpr mice.
  • To elucidate the signaling pathways involved in AICAR's anti-inflammatory effects in these cells.

Main Methods:

  • Primary kidney mesangial cells from MRL/lpr mice were cultured.
  • Cells were treated with AICAR and stimulated with LPS/IFN-gamma.
  • Levels of inducible nitric oxide synthase (iNOS), cyclooxygenase-2, and interleukin-6 were measured.
  • Signaling pathways including PI3K/Akt and NF-kappaB were analyzed.
  • The role of adenosine kinase was assessed using 5'-iodotubercidin.

Main Results:

  • AICAR dose-dependently decreased iNOS, cyclooxygenase-2, and interleukin-6 production.
  • AICAR inhibited the LPS/IFN-gamma-stimulated PI3K/Akt signaling pathway.
  • AICAR did not affect LPS/IFN-gamma-mediated NF-kappaB phosphorylation or nuclear translocation.
  • Inhibition of adenosine kinase blocked AICAR's AMPK activation and anti-inflammatory effects.

Conclusions:

  • AMPK activation by AICAR inhibits inflammatory mediator production in kidney mesangial cells.
  • The mechanism involves the inhibition of the PI3K/Akt pathway via AMPK activation.
  • AICAR demonstrates potential as a therapeutic agent for inflammatory diseases.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...